Last Updated: Monday, 11-Apr-2022 18:30:00 EDT
Phase 3 PROMINENT Cardiovascular Outcomes Study Discontinued by Kowa
Kowa Research Institute, Inc. has announced the decision to not continue its Phase 3 PROMINENT study. Read the press release. Kowa has indicated that full data will be shared at a future conference.